Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27601589.
- Also identified by DOI 10.1158/1078-0432.CCR-16-1710.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accrual continues to be a challenge for oncology clinical trials. Interventions to enhance accrual after study activation exist, including corrective action plans for NCI-sponsored trials. Clinical trials would benefit from a proactive approach rather than a reactive approach. Accrual strategy planning early in trial development is suggested. Clin Cancer Res; 22(22); 5397-9. ©2016 AACRSee related article by Massett et al., p. 5408.
Medical subject headings
- Clinical Trials as Topic
- Medical Oncology